Urology · 2026
Association Between Cannabis Use Disorder and Lower Urinary Tract Symptoms in Young Adults: A Nationwide Claims Database Study.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dishong Devin M, Giarracco Emma, Grutman Aurora J, Campbell Jack A, Gabrielson Andrew T, Cohen Andrew J
Аннотация
OBJECTIVE: To investigate the association of Cannabis Use Disorder (CUD) with new diagnoses of lower urinary tract symptoms (LUTS) in a young adult cohort.
METHODS: Using the TriNetX database, we identified patients aged 18-34 and stratified by sex and CUD diagnosis into cohorts. Propensity score matching was utilized on demographics and variables potentially affecting LUTS. The primary outcomes were 5-year risks of new onset lower urinary tract diagnoses, including all-cause LUTS, dysuria, pelvic/perineal pain, overactive bladder, and urinary tract infection, among patients with CUD compared to controls.
RESULTS: We identified 101,761 and 67,110 matched pairs of males and females, respectively. At 5-year follow-up, CUD was associated with a higher risk of new onset of all-cause LUTS in males (RR 1.69, 95% CI 1.60-1.80, P <.01) and females (RR 1.81, 95% CI 1.73-1.89, P <.01) compared to controls. Increased risks of dysuria, pelvic/perineal pain, and urinary tract infection were observed in both male and female CUD patients compared to controls (all P <.01). CUD was not associated with overactive bladder in either males or females.
CONCLUSION: In a cohort of young adults, CUD was associated with a greater risk of developing LUTS in both men and women. Further research is needed to define the impact of cannabinoids on lower urinary tract function.
METHODS: Using the TriNetX database, we identified patients aged 18-34 and stratified by sex and CUD diagnosis into cohorts. Propensity score matching was utilized on demographics and variables potentially affecting LUTS. The primary outcomes were 5-year risks of new onset lower urinary tract diagnoses, including all-cause LUTS, dysuria, pelvic/perineal pain, overactive bladder, and urinary tract infection, among patients with CUD compared to controls.
RESULTS: We identified 101,761 and 67,110 matched pairs of males and females, respectively. At 5-year follow-up, CUD was associated with a higher risk of new onset of all-cause LUTS in males (RR 1.69, 95% CI 1.60-1.80, P <.01) and females (RR 1.81, 95% CI 1.73-1.89, P <.01) compared to controls. Increased risks of dysuria, pelvic/perineal pain, and urinary tract infection were observed in both male and female CUD patients compared to controls (all P <.01). CUD was not associated with overactive bladder in either males or females.
CONCLUSION: In a cohort of young adults, CUD was associated with a greater risk of developing LUTS in both men and women. Further research is needed to define the impact of cannabinoids on lower urinary tract function.